Anzeige
Mehr »
Login
Montag, 16.09.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
JETZT EXPLODIERT SILBER: SILBER-HEBEL: Spektakuläre Einstiegs-Chance in den Silbermarkt mit dieser Aktie!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3EJLV | ISIN: US6833733024 | Ticker-Symbol: HY10
Tradegate
16.09.24
08:00 Uhr
0,187 Euro
-0,010
-4,89 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ONTRAK INC Chart 1 Jahr
5-Tage-Chart
ONTRAK INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,1880,20314:09
0,1870,20112:25
GlobeNewswire (Europe)
841 Leser
Artikel bewerten:
(2)

Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical

NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.'s securities were suspended on July 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Financial Strategies Acquisition Corp. Financial Strategies Acquisition Corp.'s securities were suspended on August 31, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Kiromic BioPharma, Inc. Kiromic BioPharma, Inc.'s securities were suspended on September 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Infinity Pharmaceuticals, Inc. Infinity Pharmaceuticals, Inc.'s securities were suspended on September 14, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Molekule Group, Inc. Molekule Group, Inc.'s securities were suspended on October 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of EBET, Inc. EBET, Inc.'s securities were suspended on October 13, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Shift Technologies, Inc. Shift Technologies, Inc.'s securities were suspended on October 19, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the preferred stock of Ontrak, Inc. Ontrak, Inc.'s securities were suspended on October 20, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of RVL Pharmaceuticals plc. RVL Pharmaceuticals plc's securities were suspended on October 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Biocept, Inc. Biocept, Inc.'s securities were suspended on October 25, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Akumin Inc. Akumin Inc.'s securities were suspended on October 26, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Appreciate Holdings, Inc. Appreciate Holdings, Inc.'s securities were suspended on October 27, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Liberty TripAdvisor Holdings, Inc. Liberty TripAdvisor Holdings, Inc.'s securities were suspended on October 30, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Tempo Automation Holdings, Inc. Tempo Automation Holdings, Inc.'s securities were suspended on November 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Medicenna Therapeutics Corp. Medicenna Therapeutics Corp.'s securities were suspended on November 2, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of RiceBran Technologies. RiceBran Technologies's securities were suspended on November 8, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the securities of Acer Therapeutics Inc. Acer Therapeutics Inc.'s securities were suspended on November 9, 2023, and have not traded on Nasdaq since that time.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.


© 2023 GlobeNewswire (Europe)
Gold - Die besten Aktien für den nächsten Preisschub

Steigen Sie jetzt ein und nutzen Sie die einmalige Chance, die Ihnen der nächste Goldpreisschub bietet!

Dieser Aktienreport stellt die besten Aktien für den kommenden Goldpreisanstieg vor. Zur ausgewogenen Diversifikation eines Depots sind Engagements in Gold oder Aktien von Goldproduzenten unerlässlich. Die letzten Monate haben gezeigt, dass Goldinvestments nicht nur stabilisierend sein können, sondern auch erhebliche Gewinne ermöglichen. Nach einer Konsolidierungsphase bieten sich nun wieder spannende Einstiegsmöglichkeiten.

Nutzen Sie diese Chance!

Fordern Sie jetzt den brandneuen Spezialreport an und erfahren Sie, welche Goldaktien das größte Potenzial haben. Dieser Report ist 100 % kostenlos und hilft Ihnen, die besten Investments im Goldsektor zu identifizieren.

Sichern Sie sich jetzt Ihren kostenfreien Report.

Um Ihnen den Report zusenden zu können, geben Sie einfach Ihre E-Mail-Adresse hier ein. Sie erhalten umgehend Zugang zu Ihrem PDF-Report. Dies ist für Sie vollkommen kostenlos und unverbindlich.

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.